According to Future Market Insights research, during the projected period, the global cryopreservation freezers market is expected to grow at a CAGR of 6.5%. The market value is projected to increase from US$ 585.0 Million in 2023 to US$ 1.1 Billion by 2033. The cryopreservation freezers market was valued at US$ 552.3 Million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 5.9% in 2023.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 552.3 Million |
Market Value 2023 | US$ 585.0 Million |
Market Value 2033 | US$ 1.1 Billion |
CAGR 2023 to 2033 | 6.5% |
Market Share of Top 5 Countries | 55.8% |
Key Companies List | ACMAS Technologies Pvt. Ltd.; Air Water Inc.; ARCTIKO AS; Aucma Co. Ltd; Avantor Inc.; BioLife Solutions, Inc.; Brooks Automation Inc.; Chart Industries Inc.; ZHONGKE MEILING CRYOGENICS CO. LTD.; Froilabo; Haier Biomedical; Hamilton Thorne Ltd.; Helmer Scientific Inc.; Panasonic Holdings Corp.; PHC Holdings Corp.; Scientific Research Instruments Co Pvt Ltd; Thermo Fisher Scientific Inc.; Wuxi Guanya Refrigeration Technology Co. Ltd.; Scimed Asia Pte Ltd.; and Stericox India Pvt. Ltd. |
The storage and preservation of biological samples have been revolutionized by cryopreservation freezers, which have become an indispensable tools in the healthcare industry. These freezers provide a practical method for maintaining the viability and integrity of cells, tissues, and organs while storing them for an extended period at very low temperatures.
The need for cryopreservation freezers has significantly increased because of developments in medical research and treatments. To ensure ideal preservation conditions, these freezers offer accurate temperature control, effective cooling, and cutting-edge cryogenic monitoring systems (CMS).
The cryopreservation freezers’ subfreezing temperature varies from below -80°C and typically below -160°C to maintain the biologics.
Cryopreservation freezers have been embraced by the healthcare industry for a variety of uses, including organ transplantation; stem cell research, and pharmaceutical development. They are essential in the search for groundbreaking medical discoveries because of their capacity to keep biological material in a stable form.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global cryopreservation freezers market recorded a historic CAGR of 5.4% in the last 5 years from 2017 to 2022. The global cryopreservation freezers market contribute around 15.0% to the global biomedical refrigerator and freezers market value at around US$ 3.6 Billion in 2022.
The market for cryopreservation freezers in the healthcare industry is being significantly driven by increased research into genetic disorders. Various medical diseases are brought on by genetic disorders, due to anomalies in a person's DNA or genes.
Understanding the underlying genetic pathways, creating tailored treatments, and improving diagnostics for various disorders are the goals of this field of study. By permitting the storage and preservation of genetic material, including DNA, RNA, and cells, for analysis and testing, cryopreservation freezers play a significant part in this study.
Cryopreservation freezers are necessary because genetic material is sensitive and needs to be kept stable and intact at extremely low temperatures. The long-term storage of genetic samples without degradation is ensured by these freezers, which offer a regulated environment with temperatures as low as -150°C or lower. Researchers can preserve the integrity of the samples over long periods of time by keeping genetic material in cryopreservation freezers, making subsequent analysis and experiments easier.
Cryopreservation freezers also provide improved sample security by lowering the possibility of contamination or sample loss. They offer chambers that are both airtight and temperature-controlled, shielding the genetic material from outside contamination and maintaining it in a stable form.
The expanding understanding of the role genetics plays in human health and disease is what is driving the surge in research into genetic disorders. New research and diagnostic opportunities for genetic illnesses have been made possible by improvements in genomic analysis technologies and genetic sequencing technologies. The need for cryopreservation freezers to store and preserve genetic material for in-depth study and testing is growing as researchers learn more about the genetic basis of diseases.
The demand for cryopreservation freezers, which are vital tools in the healthcare industry and enable researchers to store and preserve genetic material accurately and securely for advancing the understanding of genetic disorders and developing targeted therapies, is generally driven by the increased research into genetic disorders.
The cryogenic freezers industry is primarily driven by advancements in technology. Cryopreservation freezer technology has undergone constant invention and development, which has greatly increased its effectiveness, dependability, and user-friendliness. These developments have produced cutting-edge features and capabilities that meet the changing demands of the healthcare sector.
Improvements in temperature control systems due to technology include the adoption of sophisticated refrigeration methods and accurate temperature monitoring. Improved chilling techniques guarantee quick and even freezing of samples, lowering the chance of damage or cell death. Additionally, automated sample handling systems simplify the process of storing and retrieving samples, increasing operational effectiveness overall.
As per the standards of biological product manufacturing, it needs specific temperature-controlled rooms to avoid contamination there are several emerging players with their innovations to tackle this issue.
This makes the cryopreservation freezer a perfect alternative for laboratories and other organizations that need to store and maintain susceptible temperature to exchange products in a contamination-free environment. These environments include crucial cleanrooms and associated controlled conditions, such as sterile medicine and biological product manufacture using aseptic processing.
The implementation of advanced monitoring and alarm systems is another noteworthy development. These systems offer real-time information on temperature, humidity, and other crucial parameters, enabling quick action in the event of any anomalies and guaranteeing the integrity and security of stored samples.
In general, cryogenic freezer technology advances promote market expansion by offering more dependable, effective, and user-friendly solutions that meet the changing needs of the healthcare sector for sample storage and preservation.
Cryopreservation freezers' high price is a significant market growth inhibitor. First off, many potential consumers may not be able to afford these freezers due to the significant initial expenditure needed to buy and install them.
Subsequently, the ongoing costs of running cryopreservation freezers, such as energy, liquid nitrogen (LN), and routine maintenance, add to the overall financial burden. By doing this, the market is limited to businesses or facilities with adequate financial resources.
Likewise, the high price makes it difficult for smaller-scale or resource-constrained settings, like clinics or research institutions with tight budgets, to employ cryopreservation technology. As a result, the barrier created by cryopreservation freezers' high price limits the market growth potential for these devices.
The U.S. dominates the global market with a total market share of over 32.2% in 2022 and is projected to continue experiencing high growth throughout the forecast period.
The United States market for cryopreservation freezers is significantly influenced by organ transplantation. As an effective therapy option for patients with advanced organ failure, the demand for organ transplantation is rapidly rising.
In this procedure, cryopreservation freezers are essential because they retain the viability and functionality of the preserved organs at extremely low temperatures until they can be transplanted into the recipient.
The risk of harm or deterioration is reduced because of the controlled atmosphere these freezers offer, which guarantees the best preservation conditions for organs. The demand for effective and dependable cryopreservation freezers grows as the frequency of organ transplant procedures increases, propelling the expansion of the cryopreservation freezers market in the United States.
Germany holds a market share of over 6.8% in the global market in 2022.
The cryogenic freezers industry is significantly fueled by developments in biomedical research in Germany. The biomedical research industry in Germany is strong and forward thinking, with a concentration on cutting-edge fields including genetics, regenerative medicine, and customized healthcare.
These developments increase the demand for cryogenic freezers, which are necessary for preserving and storing priceless biological samples used in scientific research.
Researchers can preserve the integrity and viability of cells, tissues, and genetic material for extended periods by using cryogenic freezers. They offer accurate temperature regulation, making sure the samples are kept at the extremely low temperatures necessary for their preservation.
This enables scientists in Germany to carry out extensive and protracted studies that result in advances in the knowledge of chronic diseases, the creation of novel treatments, and customized medicine.
Cryogenic freezer demand is increasing as biomedical research flourishes in Germany. These freezers provide the infrastructure required to meet the storage and preservation requirements of various research facilities, academic institutions, and biotechnology firms, speeding scientific advancements and fueling market expansion in the German cryogenic freezers market.
China holds a 6.3% share in the global market share in 2022.
The market for cryogenic freezers is significantly being driven by China's growing stem cell banking industry. Due to the improvements in stem cell research and the increased awareness of the therapeutic potential of stem cells, China has seen a significant rise in stem cell banking.
As they offer the necessary ultra-low temperature storage conditions needed to keep stem cells viable and functional, cryogenic freezers play a significant part in stem cell banking. These freezers make it possible to preserve stem cells over an extended period, guaranteeing their accessibility for prospective treatments and regenerative therapies.
There is a growing demand for dependable cryogenic freezers that provide accurate temperature control, effective cooling, and cutting-edge monitoring systems in China as stem cell banking becomes more and more popular.
As medical facilities, stem cell banks and research facilities invest in cutting-edge freezer technology to support the developing stem cell banking sector and satisfy the needs of stem cells for storage and preservation, the cryogenic freezers market in China is expanding.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Tunnel freezer hold a revenue share of 41.2% in 2022, and the same trend is being followed over the forecasted period.
Due to its enormous capacity, effective freezing technique, and suitability for large-scale preservation requirements, the tunnel freezer segment leads the cryopreservation freezers market in the healthcare industry, making it a favored choice for keeping biological samples and medical items.
Medical and healthcare settings hold a market share of 42.3% in 2022, within the forecasted period.
Since these facilities have a greater need for preserving and storing biological samples, vaccines, pharmaceuticals, and other medical products, specialized freezer solutions are required, the medical and healthcare settings segment dominates the end-user segment in the market for cryopreservation freezers in the healthcare industry.
Growing demand for technologically advanced products in the field of cryopreservation freezers market has led companies to adopt strategies like plant expansion, increasing research and development and collaborations.
Similarly, recent developments related to companies in the cryopreservation freezers market have been tracked by the team at Future Market Insights, which are available in the full report.
Attributes | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | US$ Million for Value, Units for Volume |
Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa, and Northern Africa |
Key Market Segments Covered | Product, End User and Region |
Key Companies Profiled | ACMAS Technologies Pvt. Ltd.; Air Water Inc.; ARCTIKO AS; Aucma Co. Ltd; Avantor Inc.; BioLife Solutions, Inc.; Brooks Automation Inc.; Chart Industries Inc.; ZHONGKE MEILING CRYOGENICS CO. LTD.; Froilabo; Haier Biomedical; Hamilton Thorne Ltd.; Helmer Scientific Inc.; Panasonic Holdings Corp.; PHC Holdings Corp.; Scientific Research Instruments Co Pvt Ltd; Thermo Fisher Scientific Inc.; Wuxi Guanya Refrigeration Technology Co. Ltd.; Scimed Asia Pte Ltd.; Stericox India Pvt. Ltd. |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
The market is predicted to attain a valuation of US$ 585.0 million in 2023.
The growth potential of the market is 6.5% through 2033.
The market is expected to reach US$ 1.1 billion by 2033.
The market exhibited a 5.4% CAGR from 2017 to 2022.
ARCTIKO AS, Aucma Co. Ltd, and Avantor Inc. are the key market players.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation/Development Trends
4. Value Added Insights
4.1. Adoption Rate/Usage Analysis for
4.2. Regulatory Scenario
4.3. PESTLE Analysis
4.4. Porter's Analysis
4.5. Technology Assessment
4.6. Recent Product Approvals/Launches
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Cold Storage Market Analysis
5.2. Forecast Factors - Relevance & Impact
5.2.1. Awareness of Cryopreservation Freezers
5.2.2. Increasing Prevalence of Chronic Disease
5.2.3. Advancements in Biomedical Research
5.2.4. Growing Investment in Healthcare Expenditure
5.2.5. New Product Launch
5.2.6. Top Companies’ Historical Growth
5.2.7. Product Cost
5.2.8. Strategic Collaboration and Partnership
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (Units) Analysis, 2017 to 2022
6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
8.2. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.3.1. Y-o-Y Growth Trend Analysis
8.3.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Product, 2023 to 2033
9.3.1. Tunnel Freezer
9.3.2. IQF Freezer
9.3.3. Immersion Freezer
9.3.4. Spiral Freezer
9.3.5. Others
9.4. Market Attractiveness Analysis by Product
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis by End User , 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User , 2023 to 2033
10.3.1. Medical and Healthcare settings
10.3.2. Bio-pharma companies
10.3.3. Blood Banks
10.3.4. Research Institutes
10.3.5. Others
10.4. Market Attractiveness Analysis by End User
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East & Africa
11.4. Market Attractiveness Analysis by Region
12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By End User
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Country Level Analysis & Forecast
12.7.1. U.S Market
12.7.1.1. Introduction
12.7.1.2. Market Analysis and Forecast by Market Taxonomy
12.7.1.2.1. By Product
12.7.1.2.2. By End User
12.7.2. Canada Market
12.7.2.1. Introduction
12.7.2.2. Market Analysis and Forecast by Market Taxonomy
12.7.2.2.1. By Product
12.7.2.2.2. By End User
13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By End User
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. Brazil Market Analysis
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast by Market Taxonomy
13.7.1.2.1. By Product
13.7.1.2.2. By End User
13.7.2. Mexico Market Analysis
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast by Market Taxonomy
13.7.2.2.1. By Product
13.7.2.2.2. By End User
13.7.3. Argentina Market Analysis
13.7.3.1. Introduction
13.7.3.2. Market Analysis and Forecast by Market Taxonomy
13.7.3.2.1. By Product
13.7.3.2.2. By End User
14. Europe Market 2017 - 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. France
14.3.1.3. Spain
14.3.1.4. Italy
14.3.1.5. BENELUX
14.3.1.6. U.K.
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. Germany Market Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By End User
14.7.2. France Market Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By End User
14.7.3. Spain Market Analysis
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast by Market Taxonomy
14.7.3.2.1. By Product
14.7.3.2.2. By End User
14.7.4. Italy Market Analysis
14.7.4.1. Introduction
14.7.4.2. Market Analysis and Forecast by Market Taxonomy
14.7.4.2.1. By Product
14.7.4.2.2. By End User
14.7.5. BENELUX Market Analysis
14.7.5.1. Introduction
14.7.5.2. Market Analysis and Forecast by Market Taxonomy
14.7.5.2.1. By Product
14.7.5.2.2. By End User
14.7.6. U.K Market Analysis
14.7.6.1. Introduction
14.7.6.2. Market Analysis and Forecast by Market Taxonomy
14.7.6.2.1. By Product
14.7.6.2.2. By End User
14.7.7. Russia Market Analysis
14.7.7.1. Introduction
14.7.7.2. Market Analysis and Forecast by Market Taxonomy
14.7.7.2.1. By Product
14.7.7.2.2. By End User
15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. China Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By End User
15.7.2. Japan Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By End User
15.7.3. South Korea Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. By End User
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Thailand
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. India Market Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By End User
16.7.2. Indonesia Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By End User
16.7.3. Thailand Market Analysis
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Product
16.7.3.2.2. By End User
16.7.4. Malaysia Market Analysis
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast by Market Taxonomy
16.7.4.2.1. By Product
16.7.4.2.2. By End User
17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By End User
17.7.2. New Zealand Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By End User
18. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. Northern Africa
18.3.1.4. South Africa
18.3.1.5. Rest of MEA
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. GCC Countries Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Product
18.7.1.2.2. By End User
18.7.2. Türkiye Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Product
18.7.2.2.2. By End User
18.7.3. Northern Africa Market Analysis
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Product
18.7.3.2.2. By End User
18.7.4. South Africa Market Analysis
18.7.4.1. Introduction
18.7.4.2. Market Analysis and Forecast by Market Taxonomy
18.7.4.2.1. By Product
18.7.4.2.2. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
19.3.1. Regional footprint of Players
19.3.2. Product footprint by Players
19.3.3. Channel footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. ACMAS Technologies Pvt. Ltd.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Key Financials
20.3.1.4. Sales Footprint
20.3.1.5. SWOT Analysis
20.3.1.6. Key Developments
20.3.1.7. Strategy Overview
20.3.1.7.1. Channel Strategy
20.3.1.7.2. Marketing Strategy
20.3.1.7.3. Product Strategy
20.3.2. Air Water Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Key Financials
20.3.2.4. Sales Footprint
20.3.2.5. SWOT Analysis
20.3.2.6. Key Developments
20.3.2.7. Strategy Overview
20.3.2.7.1. Channel Strategy
20.3.2.7.2. Marketing Strategy
20.3.2.7.3. Product Strategy
20.3.3. ARCTIKO AS
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Key Financials
20.3.3.4. Sales Footprint
20.3.3.5. SWOT Analysis
20.3.3.6. Key Developments
20.3.3.7. Strategy Overview
20.3.3.7.1. Channel Strategy
20.3.3.7.2. Marketing Strategy
20.3.3.7.3. Product Strategy
20.3.4. Aucma Co. Ltd
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Key Financials
20.3.4.4. Sales Footprint
20.3.4.5. SWOT Analysis
20.3.4.6. Key Developments
20.3.4.7. Strategy Overview
20.3.4.7.1. Channel Strategy
20.3.4.7.2. Marketing Strategy
20.3.4.7.3. Product Strategy
20.3.5. Avantor Inc.
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Key Financials
20.3.5.4. Sales Footprint
20.3.5.5. SWOT Analysis
20.3.5.6. Key Developments
20.3.5.7. Strategy Overview
20.3.5.7.1. Channel Strategy
20.3.5.7.2. Marketing Strategy
20.3.5.7.3. Product Strategy
20.3.6. BioLife Solutions, Inc.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Key Financials
20.3.6.4. Sales Footprint
20.3.6.5. SWOT Analysis
20.3.6.6. Key Developments
20.3.6.7. Strategy Overview
20.3.6.7.1. Channel Strategy
20.3.6.7.2. Marketing Strategy
20.3.6.7.3. Product Strategy
20.3.7. Brooks Automation Inc.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Key Financials
20.3.7.4. Sales Footprint
20.3.7.5. SWOT Analysis
20.3.7.6. Key Developments
20.3.7.7. Strategy Overview
20.3.7.7.1. Channel Strategy
20.3.7.7.2. Marketing Strategy
20.3.7.7.3. Product Strategy
20.3.8. Chart Industries Inc.
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Key Financials
20.3.8.4. Sales Footprint
20.3.8.5. SWOT Analysis
20.3.8.6. Key Developments
20.3.8.7. Strategy Overview
20.3.8.7.1. Channel Strategy
20.3.8.7.2. Marketing Strategy
20.3.8.7.3. Product Strategy
20.3.9. ZHONGKE MEILING CRYOGENICS CO. LTD.
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Key Financials
20.3.9.4. Sales Footprint
20.3.9.5. SWOT Analysis
20.3.9.6. Key Developments
20.3.9.7. Strategy Overview
20.3.9.7.1. Channel Strategy
20.3.9.7.2. Marketing Strategy
20.3.9.7.3. Product Strategy
20.3.10. Froilabo
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Key Financials
20.3.10.4. Sales Footprint
20.3.10.5. SWOT Analysis
20.3.10.6. Key Developments
20.3.10.7. Strategy Overview
20.3.10.7.1. Channel Strategy
20.3.10.7.2. Marketing Strategy
20.3.10.7.3. Product Strategy
20.3.11. Haier Biomedical
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Key Financials
20.3.11.4. Sales Footprint
20.3.11.5. SWOT Analysis
20.3.11.6. Key Developments
20.3.11.7. Strategy Overview
20.3.11.7.1. Channel Strategy
20.3.11.7.2. Marketing Strategy
20.3.11.7.3. Product Strategy
20.3.12. Hamilton Thorne Ltd.
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Key Financials
20.3.12.4. Sales Footprint
20.3.12.5. SWOT Analysis
20.3.12.6. Key Developments
20.3.12.7. Strategy Overview
20.3.12.7.1. Channel Strategy
20.3.12.7.2. Marketing Strategy
20.3.12.7.3. Product Strategy
20.3.13. Helmer Scientific Inc.
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Key Financials
20.3.13.4. Sales Footprint
20.3.13.5. SWOT Analysis
20.3.13.6. Key Developments
20.3.13.7. Strategy Overview
20.3.13.7.1. Channel Strategy
20.3.13.7.2. Marketing Strategy
20.3.13.7.3. Product Strategy
20.3.14. Panasonic Holdings Corp.
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Key Financials
20.3.14.4. Sales Footprint
20.3.14.5. SWOT Analysis
20.3.14.6. Key Developments
20.3.14.7. Strategy Overview
20.3.14.7.1. Channel Strategy
20.3.14.7.2. Marketing Strategy
20.3.14.7.3. Product Strategy
20.3.15. PHC Holdings Corp.
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Key Financials
20.3.15.4. Sales Footprint
20.3.15.5. SWOT Analysis
20.3.15.6. Key Developments
20.3.15.7. Strategy Overview
20.3.15.7.1. Channel Strategy
20.3.15.7.2. Marketing Strategy
20.3.15.7.3. Product Strategy
20.3.16. Scientific Research Instruments Co Pvt Ltd
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Key Financials
20.3.16.4. Sales Footprint
20.3.16.5. SWOT Analysis
20.3.16.6. Key Developments
20.3.16.7. Strategy Overview
20.3.16.7.1. Channel Strategy
20.3.16.7.2. Marketing Strategy
20.3.16.7.3. Product Strategy
20.3.17. Thermo Fisher Scientific Inc.
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Key Financials
20.3.17.4. Sales Footprint
20.3.17.5. SWOT Analysis
20.3.17.6. Key Developments
20.3.17.7. Strategy Overview
20.3.17.7.1. Channel Strategy
20.3.17.7.2. Marketing Strategy
20.3.17.7.3. Product Strategy
20.3.18. Wuxi Guanya Refrigeration Technology Co. Ltd.
20.3.18.1. Overview
20.3.18.2. Product Portfolio
20.3.18.3. Key Financials
20.3.18.4. Sales Footprint
20.3.18.5. SWOT Analysis
20.3.18.6. Key Developments
20.3.18.7. Strategy Overview
20.3.18.7.1. Channel Strategy
20.3.18.7.2. Marketing Strategy
20.3.18.7.3. Product Strategy
20.3.19. Scimed Asia Pte Ltd.
20.3.19.1. Overview
20.3.19.2. Product Portfolio
20.3.19.3. Key Financials
20.3.19.4. Sales Footprint
20.3.19.5. SWOT Analysis
20.3.19.6. Key Developments
20.3.19.7. Strategy Overview
20.3.19.7.1. Channel Strategy
20.3.19.7.2. Marketing Strategy
20.3.19.7.3. Product Strategy
20.3.20. Stericox India Pvt. Ltd.
20.3.20.1. Overview
20.3.20.2. Product Portfolio
20.3.20.3. Key Financials
20.3.20.4. Sales Footprint
20.3.20.5. SWOT Analysis
20.3.20.6. Key Developments
20.3.20.7. Strategy Overview
20.3.20.7.1. Channel Strategy
20.3.20.7.2. Marketing Strategy
20.3.20.7.3. Product Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports